Agilent Technologies (NYSE:A - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday.
A number of other analysts have also commented on the stock. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. TD Cowen boosted their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a research note on Thursday. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Thursday. Bank of America upgraded shares of Agilent Technologies from a "neutral" rating to a "buy" rating and decreased their price target for the company from $150.00 to $145.00 in a research note on Thursday. Finally, Barclays raised their price objective on Agilent Technologies from $140.00 to $145.00 and gave the company an "overweight" rating in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $162.79.
Read Our Latest Report on A
Agilent Technologies Price Performance
Shares of Agilent Technologies stock opened at $135.38 on Friday. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a 50-day simple moving average of $115.93 and a two-hundred day simple moving average of $128.76. The stock has a market capitalization of $38.26 billion, a price-to-earnings ratio of 27.19, a price-to-earnings-growth ratio of 2.84 and a beta of 1.22.
Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business's quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts forecast that Agilent Technologies will post 5.97 EPS for the current year.
Institutional Trading of Agilent Technologies
A number of large investors have recently added to or reduced their stakes in A. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies during the fourth quarter worth about $26,000. SHP Wealth Management bought a new position in Agilent Technologies during the fourth quarter worth about $26,000. Board of the Pension Protection Fund purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $27,000. Navalign LLC purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $27,000. Finally, Cedar Mountain Advisors LLC purchased a new position in shares of Agilent Technologies in the first quarter worth about $27,000.
Trending Headlines about Agilent Technologies
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent beat Q2 earnings and revenue estimates, with EPS of $1.49 and revenue of $1.84 billion, both ahead of expectations. Agilent Technologies (A) Tops Q2 Earnings and Revenue Estimates
- Positive Sentiment: The company raised fiscal 2026 guidance after the strong quarter, signaling management expects momentum to continue. Agilent Lifts Outlook After 2Q Profit, Rev Rise
- Positive Sentiment: Bank of America upgraded Agilent to Buy, while TD Cowen and Barclays also lifted price targets, reinforcing the improving analyst view on the stock. Agilent Technologies shares jump on earnings beat, Bank of America upgrade
- Positive Sentiment: Market commentary highlighted Agilent’s strong execution, market share gains, and broader demand improvement across key instrument categories. Agilent Technologies Stock Soars On Broad Q2 Beat, Company Stands Out In Tools Sector
- Neutral Sentiment: Some articles compared Agilent with peers or discussed broader market themes, which are less likely to directly affect the stock near term. Agilent Technologies NYSE: A vs. Lonza Group OTCMKTS: LZAGY Head-To-Head Comparison
- Neutral Sentiment: Agilent was also mentioned in “stocks to watch” and momentum-focused coverage, reflecting continued investor attention rather than a new fundamental catalyst. Agilent Technologies, Snowflake And 3 Stocks To Watch Heading Into Friday
About Agilent Technologies
(
Get Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.